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Abstract 
 
BACKGROUND: Degenerative Cervical Myelopathy (DCM) is estimated to be the 
commonest cause of spinal cord dysfunction worldwide, with treatment largely limited to 
surgery.  Physiotherapy is often provided as part of post-operative rehabilitation with an 
unclear evidence base.  
OBJECTIVE: To review peer-reviewed literature relating to post-operative physiotherapy for 
DCM, to determine efficacy in improving clinical outcome and recovery. 
DATA SOURCES: MEDLINE, EMBASE, CENTRAL, PEDro, ISRCTN registry, WHO ICTRP 
and Clinicaltrials.gov. References and citations of relevant articles were searched. 
METHODS: A systematic search was conducted in accordance with PRISMA guidelines 
(PROSPERO CRD42016039511) from the origins of the databases till 15th February 2018. 
Included were all studies investigating physiotherapy as an intervention after surgical 
treatment of DCM to determine effect on clinical outcome and recovery. Study quality was 
determined using the Grades of Recommendation, Assessment, Development and 
Evaluation guidelines. 
RESULTS: 287 records identified through tailored systematic searches, after removing 
duplicates. After screening, only one investigated post-operative rehabilitation using 
physiotherapy for DCM, however this was retrospective with no controls. This study 
suggested that rehabilitation including physiotherapy improved post-operative recovery. 
There is currently only one registered trial investigating the use of post-operative 
physiotherapy for DCM. 
CONCLUSIONS: The literature provides insufficient evidence to make any evidence-based 
recommendations regarding post-operative physiotherapy use in DCM.  
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Introduction 
Degenerative cervical myelopathy is cervical spinal cord compression and dysfunction from 
spinal stenosis due to degeneration of the cervical spine (bone, joints, discs or ligaments). 
This includes cervical spondylotic myelopathy and ossification of the posterior longitudinal 
ligament. Degenerative cervical myelopathy is thought to be the leading cause of acquired 
spinal cord compromise.1  As a degenerative pathology, its occurrence is associated with 
age and therefore its prevalence is expected to rise.2  Symptoms are varied, ranging from 
mild pain to loss of digital dexterity, imbalance, frequent falls, incontinence and in some 
cases tetraplegia.  
 
Physiotherapy is a standard of care following many neurological injuries including spinal cord 
injury as part of neurorehabilitation programmes.3,4 It has been associated with improved 
functional outcomes in both acute and chronic spinal cord injury.3,5–7 In degenerative cervical 
myelopathy, it is primarily used for non-operative management of mild cases, but is also 
used to facilitate mobility and manage disability post-operatively.8,9 Although there is often 
some functional recovery primarily in upper limb function after surgical decompression, this 
tends to be incomplete with patients retaining lifelong disabilities10–13. Physiotherapy may 
prove particularly beneficial in optimising recovery when further spinal cord injury is 
prevented by surgical decompression.14  
 
In previous reviews of the literature on the surgical management of degenerative cervical 
myelopathy, we identified much heterogeneity in the reporting of study design, sample 
characteristics and outcomes, and proposed the development of a consensus minimum 
dataset.15,16 In this article, our primary objective is to review the evidence available for 
providing physiotherapy after surgical decompression in degenerative cervical myelopathy. 
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We will also review the surgical trials collated in our previous reviews to establish whether a 
standard for postoperative care exists. 
 
 
Methods 
Is there any evidence relating to post-operative physiotherapy in degenerative cervical 
myelopathy? 
 
A systematic search of MEDLINE [Ovid], EMBASE [Ovid], CENTRAL, PEDro, ISRCTN 
registry, WHO International Clinical Trials Registry Platform and Clinicaltrials.gov, was 
conducted in accordance with PRISMA guidelines (PROSPERO CRD42016039511).17 
Databases were searched from their origin to 15th February 2018 using a tailored search 
strategy (Supplementary Material) for all studies investigating physiotherapy as an 
intervention after surgical treatment of degenerative cervical myelopathy, and concluding an 
effect on clinical outcome and recovery. Titles and abstracts were screened for relevance. 
References and citations of full-text articles were screened for additional eligible articles 
using Scopus. Two investigators (AB and BD) independently reviewed the full text articles to 
apply the inclusion and exclusion criteria and came to agreement through discussion. 
Clinical studies of any design were included if participants suffering from degenerative 
cervical myelopathy had undergone surgical decompression and were receiving post-
operative physiotherapy. Articles were excluded if they were of non-English text, they 
contained no data on evaluation of the efficacy of post-operative physiotherapy, or were 
studies of animals or cadavers. Study quality was determined using the Grades of 
Recommendation, Assessment, Development and Evaluation framework.18  
 
Is there a standard for post-operative care in degenerative cervical myelopathy 
surgical trials and does this include physiotherapy? 
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What about: 
For our previous systematic review a search of MEDLINE and EMBASE was completed 
using the search strategy [‘Cervical’] AND [‘Myelopathy’].  Interventional studies, reported in 
English, exclusively concerning degenerative cervical myelopathy were included to consider 
the reporting of baseline characteristics (REF) and outcomes (REF).  The strategy can be 
reviewed in more detail in the aforementioned references.  The included studies were re-
examined for details post-operative care, particularly post-operative physiotherapy. Data 
extracted using a piloted extraction template. 
 
From one of our other previous systematic reviews separate to the one detailed above, we 
collated 105 clinical trials of surgery as a treatment for degenerative cervical myelopathy, 
having searched MEDLINE and EMBASE using the search strategy [‘Cervical’] AND 
[‘Myelopathy’]. .15,16 Each article was examined for details of post-operative care, particularly 
post-operative physiotherapy. Data extracted using a piloted extraction template.  
 
Results 
Is there any evidence relating to post-operative physiotherapy in degenerative 
cervical myelopathy? 
Of the 287 articles identified through our search after removing duplicates, five were 
shortlisted for full-text review based on abstract and title.19–23 Although the study by Razack 
et al. involved post-operative rehabilitation, there was no further information on what this 
meant and its efficacy was not commented on.21 Only one of the studies concluded an the 
effect of post-operative physiotherapy on degenerative cervical myelopathy clinical outcome 
and recovery.23 The screening process is summarised in the PRISMA flowchart (Figure 1). 
 
The included record was a retrospective study of 21 individuals with cervical spondylotic 
myelopathy who received surgical treatment and post-operative rehabilitation including 
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physiotherapy. Outcome was assessed in terms of a disability classification, activities of 
daily living, mobility status and the Medical Research Council grading of muscle power.23 
The study concluded that rehabilitation improved post-operative functional status. The study 
was deemed to be of low quality due to being a retrospective study with low sample size and 
no comparative group. 
 
There are two registered randomised controlled trials on clinicaltrials.gov which are planning 
to investigate the efficacy of post-operative rehabilitation in degenerative cervical 
myelopathy. One (NCT02842775) is currently in the early recruitment stage and will be 
assessing the effects of post-operative physiotherapy for balance control and the second 
(NCT03320759) is not currently recruiting but will assess the effects of post-operative 
occupational therapy.  
 
Is there a standard for post-operative care in degenerative cervical myelopathy 
surgical trials and does this include physiotherapy? 
Of the 105 surgical trials identified in this systematic review, post-operative care was detailed 
in 32 (30%), largely relating to the use of cervical collars (28, 27%).  ‘Neck exercises’ were 
reported by six (6%), but only one of these mentioned physiotherapy specifically 24.  Less 
common were surgical drains (2, 2%), courses of dexamethasone (4, 4%) and/or diuretics (2, 
2%).  
 
 
Discussion  
We found no studies evaluating the effectiveness of physiotherapy for degenerative cervical 
myelopathy after surgical decompression. Only one study was identified, which  claimed that 
post-operative rehabilitation improved functional status.23 However, this was a retrospective 
study with no comparative controls. The study was therefore deemed of very low quality 18  
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 It is apparent from our assessment of surgical trials in degenerative cervical myelopathy that 
a standard for post-operative care does not exist.  
 
Currently, physiotherapy use in degenerative cervical myelopathy is weakly evidenced only 
in mild cases as part of non-operative management.8,9 There have been no previous reviews 
of post-operative rehabilitation in degenerative cervical myelopathy. Whilst no evidence was 
found to support post-operative physiotherapy in degenerative cervical myelopathy, 
promising data from other forms of spinal cord injury, both acute and chronic alongside the 
preclinical evidence, suggests this is worth exploring further.3,5–7 The potential benefit of 
post-operative physiotherapy may not just be restricted to improvement in overall function. In 
a recent imaging study, the fat content of neck muscles in in people with degenerative 
cervical myelopathy was found to differ and its distribution related to pain scores.25 This 
raises the possibility that physiotherapy may improve pain, an outcome highly valued by 
people with degenerative cervical myelopathy.15  
 
Commissioning of neurorehabilitation worldwide is challenged by its evidence base and with 
the increasing financial demands on healthcare systems, further clinical investigation is 
required.4 The unclear benefit or harm of post-operative physiotherapy must be clarified. 
Enhancing recovery post-operatively in degenerative cervical myelopathy has been a 
relatively recent research focus but represents a major unmet clinical need.10 This has led to 
both the CSM-PROTECT trial (NCT01257828) and the soon to start RECEDE-Myelopathy, 
both investigating the potential neurological benefits of a medical adjuvant to surgical 
decompression to enhance functional recovery. If these trials deliver results, it will further 
focus attention on standards of post-operative care. 
 
Post-operative physiotherapy is currently used in degenerative cervical myelopathy, however 
its underreporting in interventional trials, as identified here, has greatly limited any 
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consideration of its clinical impact.  The development of a standardized reporting process 
would support this area of research, both in terms of interventions and outcomes, to 
generate knowledge and inform future high quality clinical trials of post-operative 
physiotherapy in degenerative cervical myelopathy.  A similar process is underway for acute 
Spinal Cord Injury.  This would be a natural extension to our aims of developing a consensus 
minimum dataset for treatment studies in degenerative cervical myelopathy.     
 
While it is possible that some records may have been missed by the search strategy used, 
this risk has been mitigated by searching references and citations of relevant records 
captured and consulting experts in the field. The systematic review of surgical trials in 
degenerative cervical myelopathy was limited to a period of 20 years, so will not capture 
potentially relevant studies outside this.15,16 Although this will reduce the number of studies 
identified, arguably, it is the recent studies that are more relevant to current research 
practice.  
 
In conclusion, we are unable to make an evidence-based recommendation for or against the 
use of post-operative physiotherapy in degenerative cervical myelopathy, as there are no 
studies evaluating its effectiveness. Moreover, there is no standard for post-operative care in 
the surgical trials reviewed. With significant promise in the field of spinal cord injury, further 
research is required to determine if there is a role for post-operative physiotherapy in 
degenerative cervical myelopathy.   
 
Clinical message 
 There are no controlled studies evaluating whether physiotherapy causes benefit, 
harm or neither after surgical decompression in patients with degenerative cervical 
myelopathy. Therefore, there is insufficient evidence to make evidence-based 
recommendation regarding this. 
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Figure 1: PRISMA flow diagram17 
 
 
 
 
 
 
 
 
 
 
13 | P a g e  
 
 
Supplementary Material: Search Strategy and PRISMA Checklist 
 
Search strategy 
 
MEDLINE 
1. exp Neck/ 
2. neck.ti,ab. 
3. exp Cervical Vertebrae/ 
4. or/1-3 
5. exp Spinal Cord Compression/ 
6. exp Spinal Osteophytosis/ 
7. spondylosis/ 
8. (cervical adj5 (compress$ or stenosis or herniat$ or degenerat$ or decompress$)).ti,ab. 
9. myelopathy.mp. 
10. (myeloradiculopathy or radiculomyelopathy).mp. 
11. or/5-10 
12. Postoperative Care/ 
13. exp physical therapy modalities/ 
14. (physical therap$ or physiotherap$).tw. 
15. exp exercise therapy/ 
16. rh.fs. 
17. exp rehabilitation/ or exp occupational therapy/ 
18. (rehabilitat$ or occupational therap$).tw. 
19. or/12-18 
20. randomized controlled trial.pt. 
21. controlled clinical trial.pt. 
22. randomized controlled trials.sh. 
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23. random allocation.sh. 
24. double blind method.sh. 
25. single-blind method.sh. 
26. clinical trial.pt. 
27. exp clinical trials as topic/ 
28. (clin$ adj25 trial$).ti,ab. 
29. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or maske$)).tw. 
30. placebos.sh. 
31. placebo$.ti,ab. 
32. random$.ti,ab. 
33. research design.sh. 
34. pragmatic clinical trial.pt. 
35. comparative study.pt. 
36. randomi#ed.ti,ab. 
37. randomly.ab,ti. 
38. trial.ab,ti. 
39. groups.ab. 
40. exp Cohort Studies/ 
41. cohort$.ti,ab. 
42. comparative$.ti,ab. 
43. prospective$.ti,ab. 
44. or/20-43 
45. (animal not human).sh. 
46. 44 not 45 
47. 4 and 11 and 19 and 46 
 
EMBASE 
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1. Clinical Article/  
2. exp Clinical Study/  
3. Clinical Trial/  
4. Controlled Study/  
5. Randomized Controlled Trial/  
6. Major Clinical Study/  
7. Double Blind Procedure/  
8. Multicenter Study/  
9. Single Blind Procedure/  
10. Phase 3 Clinical Trial/  
11. Phase 4 Clinical Trial/  
12. crossover procedure/ 
13. placebo/  
14. or/1-13  
15. allocat$.mp.  
16. assign$.mp.  
17. blind$.mp.  
18. (clinic$ adj25 (study or trial)).mp.  
19. compar$.mp.  
20. control$.mp.  
21. cross?over.mp. 
22. factorial$.mp.  
23. follow?up.mp.  
24. placebo$.mp.  
25. prospectiv$.mp.  
26. random$.mp.  
27. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).mp.  
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28. trial.mp.  
29. (versus or vs).mp.  
30. or/15-29  
31. 14 and 30  
32. human/  
33. Nonhuman/  
34. exp Animal/  
35. Animal Experiment/  
36. 33 or 34 or 35  
37. 32 not 36  
38. 31 not 36  
39. 37 and 38  
40. 38 or 39  
41. exp Neck/  
42. neck.mp.  
43. exp Cervical Spine/  
44. exp Cervical Spondylosis/  
45. or/42-44  
46. Spinal Cord Compression/  
47. myelopathy.mp.  
48. exp Myeloradiculopathy/  
49. radiculomyelopathy.mp.  
50. or/46-49  
51. exp Surgery/  
52. surgery.mp.  
53. surgical.mp.  
54. or/51-53  
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55. exp Physiotherapy/  
56. exp Rehabilitation/  
57. exp Exercise/  
58. physical therapy.mp.  
59. exercise.mp.  
60. rehabilitation.mp.  
61. physiotherapy.mp.  
62. or/55-61  
63. 40 and 45 and 50 and 54 and 62 
 
CENTRAL 
1. MeSH descriptor Neck, this term only  
2. MeSH descriptor Neck Pain, this term only  
3.  (neck)  
4. MeSH descriptor Cervical Vertebrae explode all trees  
5. (#1 OR #2 OR #3 OR #4)  
6. MeSH descriptor Spinal Cord Compression explode all trees  
7. MeSH descriptor Spinal Osteophytosis explode all trees  
8. myelopathy  
9. radiculomyelopathy  
10. myeloradiculopathy  
11. (#6 OR #7 OR #8 OR #9 OR #10)  
12. MeSH descriptor Surgery explode all trees  
13. MeSH descriptor Surgical Procedures, Operative explode all trees  
14. surgery  
15. surgical  
16. (#12 OR #13 OR#14 OR #15)  
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17. MeSH descriptor Physical Therapy (Speciality) explode all trees 
18. MeSH descriptor Physical Therapy Modalities explode all trees 
19. physical therapy 
20. physiotherapy 
21. MeSH descriptor Exercise explode all trees 
22. Exercise 
23. MeSH descriptor Rehabilitation explode all trees 
24. Rehabilitation 
25. (#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24) 
26. (#5 AND #11 AND #16 AND #25) 
 
Clinicaltrials.gov 
1. Cervical Myelopathy AND (physical therapy OR physiotherapy OR exercise OR 
rehabilitation) 
 
ISRCTN registry (http://www.isrctn.com/editAdvancedSearch) 
 
1. Cervical Myelopathy AND (physical therapy OR physiotherapy OR exercise OR 
rehabilitation) 
 
World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) 
(http://apps.who.int/trialsearch/) 
 
1. Cervical Myelopathy AND (physical therapy OR physiotherapy OR exercise OR 
rehabilitation) 
 
PEDro (https://www.pedro.org.au/) 
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1. Cervical Myelopathy AND (physical therapy OR physiotherapy OR exercise OR 
rehabilitation) 
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PRISMA Checklist 
 
Section/topic 
 
# 
 
Checklist item 
Reported 
on page # 
TITLE  
Title 1 Identify the report as a systematic review, meta-analysis, or both.          1 
ABSTRACT  
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number. 
         2 
INTRODUCTION  
Rationale 3 Describe the rationale for the review in the context of what is already known.          3 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
         4 
METHODS  
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
         4 
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale. 
         4 
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched. 
         4 
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated. 
        
Appendix  
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis). 
        4 
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators. 
        NA   
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Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
        NA 
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis. 
        4 
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means).         NA 
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I
2
) for each meta-analysis. 
        NA 
 
 
 
Section/topic 
 
# 
 
Checklist item 
Reported 
on page # 
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies). 
       NA 
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified. 
       NA 
RESULTS  
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram. 
       5 
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
       5 
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).        5  
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
       NA 
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.        NA 
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15).        NA 
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).        NA 
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DISCUSSION  
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers). 
       7 
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias). 
       8, 9 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.        7-9 
FUNDING  
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review. 
        10 
 
